Equillium Inc. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for severe autoimmune and inflammatory disorders. With a strong pipeline of drugs targeting unmet medical needs, Equillium is poised to make a significant impact in the field of immunology.
Notification